1. The Surge in Human Papillomavirus Vaccine Rejection in Nigeria.
- Author
-
Otorkpa OJ, Onifade AA, and Otorkpa CO
- Subjects
- Humans, Nigeria epidemiology, Female, Adolescent, Child, Health Knowledge, Attitudes, Practice, Immunization Programs organization & administration, Patient Acceptance of Health Care statistics & numerical data, Health Education, Vaccination statistics & numerical data, Vaccination methods, Papillomavirus Vaccines administration & dosage, Papillomavirus Infections prevention & control, Papillomavirus Infections epidemiology, Papillomavirus Infections virology, Uterine Cervical Neoplasms prevention & control, Uterine Cervical Neoplasms epidemiology, Uterine Cervical Neoplasms virology
- Abstract
In October 2023, Nigeria integrated the single-dose human papillomavirus (HPV) vaccine into its routine immunization program, aiming to protect 7.7 million girls aged 9 to 14 years. This milestone in the fight against HPV-related cancers, especially cervical cancer, faces significant challenges due to high vaccine rejection rates driven by misinformation and cultural barriers. Despite the vaccine's proven safety and efficacy, uptake remains low. This communication highlights the urgent need for a comprehensive public health education campaign to address these barriers. Proposed strategies include leveraging digital health technologies, integrating HPV education into school curricula, training community health workers, engaging religious and cultural leaders, and launching media campaigns featuring personal narratives. Implementing these evidence-based interventions is crucial for dispelling myths, misconceptions, and skepticism surrounding HPV vaccines. This will enhance acceptance and uptake, ultimately reducing cervical cancer mortality in Nigeria., (©2024 American Association for Cancer Research.)
- Published
- 2024
- Full Text
- View/download PDF